Dr. Neil Shah                 CML        Chronic Myeloid Leukemia

    Dr. Neil Shah is an Assistant Professor, Division of Hematology/Oncology, University of California, San Francisco (UCSF) School of Medicine

Extract of http://cancer.ucsf.edu/people/shah_neil.php

---

VIDEOS

CML Horizons 2014: Outlook - the future of CML therapy (Neil Shah)
May 20, 2014, cmladvocates

Understanding Molecular Response with Respect to Cure
January 25, 2012, Patient Power
                                                                  
The DASISION chronic myeloid leukaemia trial – ASH2010
February 18, 2011, ecancer.tv

Do 3rd Generation Medicines Lie Ahead for CML?                    
December 4, 2010,  Patient Power , ASH 2010, Orlando

Dr. Neil Shah at the 2009 Cancer Forum Part 1 of 2      Part 2 of 2  
September 1, 2009, winecelebration

                        

ARTICLES

TKI Discontinuation Criteria Established in Updated NCCN CML Guideline
March 23, 2019, OncLive

​Emerging Agents, TKI Discontinuation Focal Points of CML Research
October 29, 2018, OncLive